• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Allergan Cuts Jan 2017

Quote

anonymous

Guest
Seeing as everyone has questions about this I thought we can keep it clean on one list. I have not heard anything yet personally and worried but post your city/state, and department if you got let go so far....
 




anonymous said:
Seeing as everyone has questions about this I thought we can keep it clean on one list. I have not heard anything yet personally and worried but post your city/state, and department if you got let go so far....
Click to expand...

I heard today that everyone being let go has been told. If you haven't heard yet then you should be safe.
 




Medicinal Chemistry R&D Irvine were all let go. Getting rid of your discovery group (even though token group) signals the complete Valeant approach to pharmaceuticals or perhaps a buyout interest by a pharma company so strong in their own R&D that they dont need or want Allergan's remaining people!
 




I heard that all of Pharm Sciences Operations was let go. This pretty much signals that all further clinical development will be at a CMO or possibly another Allergan/Actavis site.
 
































Lynch to managed markets and Renner taking over all sales channels. Headcount reductions in line with what we already heard last week- roughly 8% overall but will affect different forces at different percentages based on matrix. Also this will be an opportunity to cut deadwood no matter what sales force- if you're bottom 10% you're gone.
 




anonymous said:
Lynch to managed markets and Renner taking over all sales channels. Headcount reductions in line with what we already heard last week- roughly 8% overall but will affect different forces at different percentages based on matrix. Also this will be an opportunity to cut deadwood no matter what sales force- if you're bottom 10% you're gone.
Click to expand...

Is hospital/antibiotic division safe this time?
 




anonymous said:
Lynch to managed markets and Renner taking over all sales channels. Headcount reductions in line with what we already heard last week- roughly 8% overall but will affect different forces at different percentages based on matrix. Also this will be an opportunity to cut deadwood no matter what sales force- if you're bottom 10% you're gone.
Click to expand...

If CR is really taking over Sales I got out just in time.

#giraffelivesmatter
 








anonymous said:
Lynch to managed markets and Renner taking over all sales channels. Headcount reductions in line with what we already heard last week- roughly 8% overall but will affect different forces at different percentages based on matrix. Also this will be an opportunity to cut deadwood no matter what sales force- if you're bottom 10% you're gone.
Click to expand...
 




















Top Bottom
Back
Quote